1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Vaccine Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunotherapeutic Vaccines
1.4.3 Booster Vaccines
1.4.4 Others
1.5 Market by Application
1.5.1 Global Tuberculosis Vaccine Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Vaccine Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Vaccine Treatment Growth Trends by Regions
2.2.1 Tuberculosis Vaccine Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Vaccine Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Vaccine Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Vaccine Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Vaccine Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Vaccine Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Vaccine Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Vaccine Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Vaccine Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2019
3.3 Tuberculosis Vaccine Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Vaccine Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Vaccine Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Vaccine Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Vaccine Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Vaccine Treatment Market Size (2015-2020)
6.2 Tuberculosis Vaccine Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tuberculosis Vaccine Treatment Market Size (2015-2020)
7.2 Tuberculosis Vaccine Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
8 China
8.1 China Tuberculosis Vaccine Treatment Market Size (2015-2020)
8.2 Tuberculosis Vaccine Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tuberculosis Vaccine Treatment Market Size (2015-2020)
9.2 Tuberculosis Vaccine Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tuberculosis Vaccine Treatment Market Size (2015-2020)
10.2 Tuberculosis Vaccine Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
11 India
11.1 India Tuberculosis Vaccine Treatment Market Size (2015-2020)
11.2 Tuberculosis Vaccine Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tuberculosis Vaccine Treatment Market Size (2015-2020)
12.2 Tuberculosis Vaccine Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Vaccine Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Vaccine Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Vaccine Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Vaccine Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Tuberculosis Vaccine Treatment Introduction
13.2.4 Merck Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Details
13.3.2 Serum Institute of India Business Overview
13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Introduction
13.3.4 Serum Institute of India Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.3.5 Serum Institute of India Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Tuberculosis Vaccine Treatment Introduction
13.4.4 GlaxoSmithKline Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Japan BCG Lab
13.5.1 Japan BCG Lab Company Details
13.5.2 Japan BCG Lab Business Overview
13.5.3 Japan BCG Lab Tuberculosis Vaccine Treatment Introduction
13.5.4 Japan BCG Lab Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.5.5 Japan BCG Lab Recent Development
13.6 IDT Biologics
13.6.1 IDT Biologics Company Details
13.6.2 IDT Biologics Business Overview
13.6.3 IDT Biologics Tuberculosis Vaccine Treatment Introduction
13.6.4 IDT Biologics Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.6.5 IDT Biologics Recent Development
13.7 GreenSignal Bio Pharma
13.7.1 GreenSignal Bio Pharma Company Details
13.7.2 GreenSignal Bio Pharma Business Overview
13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Introduction
13.7.4 GreenSignal Bio Pharma Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.7.5 GreenSignal Bio Pharma Recent Development
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Details
13.8.2 Taj Pharmaceuticals Business Overview
13.8.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Introduction
13.8.4 Taj Pharmaceuticals Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.8.5 Taj Pharmaceuticals Recent Development
13.9 Bavarian Nordic
13.9.1 Bavarian Nordic Company Details
13.9.2 Bavarian Nordic Business Overview
13.9.3 Bavarian Nordic Tuberculosis Vaccine Treatment Introduction
13.9.4 Bavarian Nordic Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.9.5 Bavarian Nordic Recent Development
13.10 China National Biotec Group
13.10.1 China National Biotec Group Company Details
13.10.2 China National Biotec Group Business Overview
13.10.3 China National Biotec Group Tuberculosis Vaccine Treatment Introduction
13.10.4 China National Biotec Group Revenue in Tuberculosis Vaccine Treatment Business (2015-2020)
13.10.5 China National Biotec Group Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Sanofi、Merck、Serum Institute of India、GlaxoSmithKline、Japan BCG Lab、IDT Biologics、GreenSignal Bio Pharma、Taj Pharmaceuticals、Bavarian Nordic、China National Biotec Group
【免責事項】
https://www.globalresearch.jp/disclaimer